Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:19 AM
Ignite Modification Date:
2025-12-25 @ 12:19 AM
NCT ID:
NCT03475758
Eligibility Criteria:
Inclusion Criteria:
Premenopausal cancer patients who will receive Cyclophosphamide-containing chemotherapy.
Exclusion Criteria:
postmenopausal cancer patients. cancer patients who will receive non Cyclophosphamide containing chemotherapy.
Healthy Volunteers:
False
Sex:
FEMALE
Study:
NCT03475758
Study Brief:
Protocol Section:
NCT03475758